Aldosterone alters the participation of endothelial factors in noradrenaline vasoconstriction differently in resistance arteries from normotensive and hypertensive rats

European Journal of Pharmacology

Volumn 654, Issue 3, 2011, Pages 280-288

  Xavier, Fabiano E ^b   Blanco Rivero, Javier ^a   Avendaño, María Soledad ^a   Sastre, Esther ^a   Yela, Rubén ^a   Velázquez, Kyra ^a   Salaíces, Mercedes ^a   Balfagón, Gloria ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b DEPARTAMENTO DE MICOLOGIA   (Brazil)

Author keywords

Aldosterone; Mesenteric resistance artery; Nitric oxide; Prostaglandin I2; Superoxide anion; Thromboxane A2

Indexed keywords

5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; 6 OXOPROSTAGLANDIN F1 ALPHA; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ALDOSTERONE; COLLAGEN TYPE 1; FUREGRELATE; HYDROCORTISONE; INDOMETACIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NORADRENALIN; POTASSIUM CHLORIDE; PROSTACYCLIN; SUPEROXIDE; TEMPOL; THROMBOXANE A2; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY RESISTANCE; ARTICLE; BIOSYNTHESIS; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; CATECHOLAMINE RELEASE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FLUORESCENCE ANALYSIS; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CONTRACTION; VASOCONSTRICTION;

ALDOSTERONE; ANIMALS; BLOOD PRESSURE; COLLAGEN TYPE I; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; HYDROCORTISONE; HYPERTENSION; MALE; MESENTERIC ARTERIES; NITRIC OXIDE; NOREPINEPHRINE; POTASSIUM CHLORIDE; PROSTAGLANDINS; RATS; RATS, INBRED WKY; SUPEROXIDES; VASOCONSTRICTION;

EID: 79951676606     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.01.007     Document Type: Article

References (37)

1. Y. Alvarez, A.M. Briones, G. Balfagon, M.J. Alonso, and M. Salaices Hypertension increases the participation of vasoconstrictor prostanoids from cyclooxygenase-2 in phenylephrine responses J. Hypertens. 23 2005 767 777 (Pubitemid 40523275)
2. G. Balfagón, I. Márquez-Rodas, Y. Alvarez, M.J. Alonso, V. Cachofeiro, M. Salaices, and V. Lahera Aldosterone modulates neural vasomotor response in hypertension: role of calcitonin gene-related peptide Regul. Pept. 120 1-3 2004 253 260 (Pubitemid 38726214)
3. J. Bauersachs Aldosterone antagonism in heart failure: improvement of cardiac remodelling, endothelial dysfunction and platelet activation Eur J Clin Invest 34 2004 649 652 (Pubitemid 39423021)
4. J. Blanco-Rivero, V. Cachofeiro, V. Lahera, R. Aras-Lopez, I. Marquez-Rodas, M. Salaices, F.E. Xavier, M. Ferrer, and G. Balfagón Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats Hypertension 46 2005 107 112 (Pubitemid 40946499)
5. V. Cachofeiro, M. Miana, N. de Las Heras, B. Martín- Fernández, S. Ballesteros, J. Fernández-Tresguerres, and V. Lahera Aldosterone and the vascular system J. Steroid Biochem. Mol. Biol. 109 2008 331 335
6. 2 in the altered microvascular reactivity in two-kidney, one-clip hypertension Endothelium 5 1997 167 178 (Pubitemid 27390276)
7. D. Duprez, M. De Buyzere, E.R. Rietzschel, and D.L. Clement Aldosterone and vascular damage Curr. Hypertens. Rep. 2 2000 327 334
8. C.A. Farquharson, and A.D. Struthers Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure Circulation 101 2000 594 597 (Pubitemid 30094728)
9. E.M. Freel, and J.M. Connell Mechanisms of hypertension: the expanding role of aldosterone J. Am. Soc. Nephrol. 15 2004 1993 2001 (Pubitemid 39031338)
10. J.W. Funder Aldosterone, mineralocorticoid receptors and vascular inflammation Mol. Cell. Endocrinol. 217 2004 263 269 (Pubitemid 38596652)
11. G. Giebisch Renal potassium transport: mechanisms and regulation Am. J. Physiol. 274 1998 817 833
12. G. Giebisch, and W. Wang Renal tubule potassium channels: function, regulation and structure Acta Physiol. Scand. 170 2000 153 173
13. P. Gluais, M. Lonchampt, J.D. Morrow, P.M. Vanhoutte, and M. Feletou Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin Br. J. Pharmacol. 146 2005 834 845 (Pubitemid 41622250)
14. A.P. McKee, D.A. Van Riper, C.A. Davison, and H.A. Singer Gender-dependent modulation of alpha 1-adrenergic responses in rat mesenteric arteries Am. J. Physiol. Heart Circ. Physiol. 284 2003 1737 1743
15. 2+ levels, and vasoconstriction in mesenteric resistance vessels Endocrinology 146 2005 973 980 (Pubitemid 40289282)
16. K. Miyagawa, M. Ohashi, S. Yamashita, M. Kojima, K. Sato, R. Ueda, and Y. Dohi Increased oxidative stress impairs endothelial modulation of contractions in arteries from spontaneously hypertensive rats J. Hypertens. 25 2007 415 421 (Pubitemid 46071940)
17. M.J. Mulvany, and W. Halpern Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats Circ. Res. 41 1977 19 26 (Pubitemid 8132079)
18. D. Nagata, M. Takahashi, K. Sawai, T. Tagami, T. Usui, A. Shimatsu, Y. Hirata, and M. Naruse Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity Hypertension 48 2006 165 171 (Pubitemid 44297539)
19. M.F. Neves, F. Amiri, A. Virdis, Q.N. Diep, and E.L. Schiffrin Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy Can. J. Physiol. Pharmacol. 83 2005 999 1006 (Pubitemid 43385544)
20. A.S. Padilha, F.M. Peçanha, D.V. Vassallo, M.J. Alonso, and M. Salaices Ouabain treatment changes the role of endothelial factors in rat resistance arteries Eur. J. Pharmacol. 600 1-3 2008 110 116
21. L.G. Palmer Potassium secretion and the regulation of distal nephron K channels Am. J. Physiol. 277 1999 821 825
22. L.G. Palmer, and G. Frindt Aldosterone and potassium secretion by the cortical collecting duct Kidney Int. 57 2000 1324 1328 (Pubitemid 30207886)
23. B. Pitt, F. Zannad, W.J. Remme, R. Cody, A. Castaigne, A. Perez, J. Palensky, and J. Wittes The effect of spironolactone on morbidity and mortality in patients with severe heart failure, Randomized Aldactone Evaluation Study Investigators N. Engl. J. Med. 341 1999 709 717 (Pubitemid 29407370)
24. R.E. Purdy, and M.A. Weber Enhancement and prolongation of vascular smooth muscle contraction by aldosterone Blood Vessels 20 1983 34 43 (Pubitemid 13181074)
25. R. Rocha, and J.W. Funder The pathophysiology of aldosterone in the cardiovascular system Ann. NY Acad. Sci. 970 2002 89 100 (Pubitemid 35286086)
26. D. Sanz-Rosa, E. Cediel, N. de las Heras, M. Miana, G. Balfagon, V. Lahera, and V. Cachofeiro Participation of aldosterone in the vascular inflammatory response of spontaneously hypertensive rats: role of the NFkappaB/IkappaB system J. Hypertens. 23 2005 1167 1172 (Pubitemid 40862720)
27. E.L. Schiffrin Effects of aldosterone on the vasculature Hypertension 47 2006 312 318 (Pubitemid 43740260)
28. B.M. Schmidt, S. Oehmer, C. Delles, R. Bratke, M.P. Schneider, A. Klingbeil, E.H. Fleischmann, and R.E. Schmieder Rapid nongenomic effects of aldosterone on human forearm vasculature Hypertension 42 2003 156 160 (Pubitemid 36944589)
29. C.T. Stier, P.N. Chander, and R. Rocha Aldosterone as a mediator in cardiovascular injury Cardiol. Rev. 10 2002 97 107 (Pubitemid 34246658)
30. H. Suzuki, H. Ikezaki, D. Hong, and I. Rubinstein PGH(2)-TxA(2)-receptor blockade restores vasoreactivity in a new rodent model of genetic hypertension J. Appl. Physiol. 88 2000 1983 1988 (Pubitemid 30453901)
31. A. Tabernero, J. Giraldo, and E. Vila Modelling the changes due to the endothelium and hypertension in the a-adrenoreceptor-mediated responses of rat aorta J. Auton. Pharmacol. 19 1999 219 228 (Pubitemid 29537440)
32. A. Virdis, M.F. Neves, F. Amiri, E. Viel, R.M. Touyz, and E.L. Schiffrin Spironolactone improves angiotensin-induced vascular changes and oxidative stress Hypertension 40 2002 504 510
33. M.A. Weber, R.E. Purdy, and J.I. Drayer Interactions of mineralocorticoids and pressor agents in vascular smooth muscle Hypertension 5 1983 41 46
34. F.E. Xavier, A.P. Davel, L.V. Rossoni, and D.V. Vassallo Time-dependent hyperreactivity to phenylephrine in aorta from untreated diabetic rats: role of prostanoids and calcium mobilization Vascul Pharmacol 40 2003 67 76 (Pubitemid 36401581)
35. F.E. Xavier, L.V. Rossoni, M.J. Alonso, G. Balfagón, D.V. Vassallo, and M. Salaices Ouabain-induced hypertension alters the participation of endothelial factors in alpha-adrenergic responses differently in rat resistance and conductance mesenteric arteries Br. J. Pharmacol. 143 2004 215 225 (Pubitemid 39280041)
36. 2 and prostacyclin Br. J. Pharmacol. 154 2008 1225 1235 (Pubitemid 351992068)
37. F.E. Xavier, J. Blanco-Rivero, M. Ferrer, and G. Balfagón Endothelium modulates vasoconstrictor response to prostaglandin I2 in rat mesenteric resistance arteries: interaction between EP1 and TP receptors Br. J. Pharmacol. 158 7 2009 1787 1795